대장암의 침습적 경계면에서 EGFR 발현의 임상병리학적 의의
Clinicopathologic Significances of EGFR Expression at Invasive Front of Colorectal Cancer
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background : Epidermal growth factor receptor (EGFR) is frequently expressed in the invasive front of colorectal cancer (CRC), but its clinicopathologic significance remains unclear. We investigated the clinical value of the EGFR expression at the invasive front of CRC. Methods : We performed an immunohistochemical analysis in order to examine the expression and distribution of EGFR in 214 cases of CRC. The EGFR status was considered positive when ≥1% of the tumor cells had membranous staining. Results : Overall, an EGFR expression was observed in 144 (67%) cases and it had no significant relationship with the clinicopathologic parameters. However, an EGFR expression at the invasive front was correlated with lymphatic invasion, lymph node metastasis and a high level of serum carcinoembryonic antigen (p = 0.028, p = 0.043, and p = 0.045, respectively). For the budding-positive CRCs liver metastases were found in the cases with an EGFR expression at the budding, but no liver metastasis occurred in the EGFR negative cases at the budding (p = 0.030). Conclusions : An EGFR expression at the invasive front has clinicopathologic significances in patients with CRC. An EGFR expression at tumor cell budding is a pathologic marker that suggests the high potential for liver metastasis in CRC.
Abstract
Background : Epidermal growth factor receptor (EGFR) is frequently expressed in the invasive front of colorectal cancer (CRC), but its clinicopathologic significance remains unclear. We investigated the clinical value of the EGFR expression at the invasive front of CRC. Methods : We performed an immunohistochemical analysis in order to examine the expression and distribution of EGFR in 214 cases of CRC. The EGFR status was considered positive when ≥1% of the tumor cells had membranous staining. Results : Overall, an EGFR expression was observed in 144 (67%) cases and it had no significant relationship with the clinicopathologic parameters. However, an EGFR expression at the invasive front was correlated with lymphatic invasion, lymph node metastasis and a high level of serum carcinoembryonic antigen (p = 0.028, p = 0.043, and p = 0.045, respectively). For the budding-positive CRCs liver metastases were found in the cases with an EGFR expression at the budding, but no liver metastasis occurred in the EGFR negative cases at the budding (p = 0.030). Conclusions : An EGFR expression at the invasive front has clinicopathologic significances in patients with CRC. An EGFR expression at tumor cell budding is a pathologic marker that suggests the high potential for liver metastasis in CRC.
참고문헌 (29)
- Carpenter G, "Epidermal growth factor", J Biol Chem, 265, pp.7709~7712 (1990)
- Yarden Y, "Untangling the ErbB signalling network", Nat Rev Mol Cell Biol, 2, pp.127~137 (2001)
- Baselga J, "Targeting the epidermal growth factor receptor with tyrosine kinase inhibitors:small molecules,big hopes", J Clin Oncol, 20, pp.2217~2219 (2002)
- Kim ES, "Epidermal growth factor receptor biology(IMC-C225)", Curr Opin Oncol, 13, pp.506~513 (2001)
- 박세훈, "Epidermal Growth Factor Receptor Mutations and the Clinical Outcome in Male Smokers with Squamous Cell Carcinoma of Lung", Journal of Korean Medical Science, 24(3), pp.448~452 (2009), 대한의학회
- Jun Mo Kim, "Prognostic Significance of Basal Markers in Triple-negative Breast Cancers", Journal of Breast Cancer, 12(1), pp.4~13 (2009), 한국유방암학회
- 조은윤, "Comparison of Her-2, EGFR and Cyclin D1 in Primary Breast Cancer and Paired Metastatic Lymph Nodes: An Immunohistochemical and Chromogenic In Situ Hybridization Study", Journal of Korean Medical Science, 23(6), pp.1053~1061 (2008), 대한의학회
- Goldstein NS, "Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer Stage IV colon adenocarcinoma:implications for a standardized scoring system", Cancer, 92, pp.1331~1346 (2001)
- Ueno H, "A new prognostic staging system for rectal cancer", Ann Surg, 240, pp.832~839 (2004)
- Okuyama T, "Budding as a useful prognostic marker in pT3 well-or moderately-differentiated rectal adenocarcinoma", J Surg Oncol, 83, pp.42~47 (2003)
- Tanaka M, "Tumor budding at the invasive margin can predict patients at high risk of recurrence after curative surgery for stage II,T3 colon cancer", Dis Colon Rectum, 46, pp.1054~1059 (2003)
- Okuyama T, "Budding is useful to select high-risk patients in stage II well-differentiated or moderately differentiated colon adenocarcinoma", Dis Colon Rectum, 46, pp.1400~1406 (2003)
- Ueno H, "Tumour ‘budding’ as an index to estimate the potential of aggressiveness in rectal cancer", Histopathology, 40, pp.127~132 (2002)
- Okuyama T, "Budding(sprouting)as a useful prognostic marker in colorectal mucinous carcinoma", Jpn J Clin Oncol, 32, pp.412~416 (2002)
- Park KJ, "Intensity of tumor budding and its prognostic implications in invasive colon carcinoma", Dis Colon Rectum, 48, pp.1597~1602 (2005)
- McKay JA, "Evaluation of the epidermal growth factor receptor(EGFR)in colorectal tumours and lymph node metastases", Eur J Cancer, 38, pp.2258~2264 (2002)
- Prewett MC, "Enhanced antitumor activity of anti-epidermal growth factor receptor monoclonal antibody IMC-C225 in combination with irinotecan(CPT-11)against human colorectal tumor xenografts", Clin Cancer Res, 8, pp.994~1003 (2002)
- Kopp R, "Reduced survival of rectal cancer patients with increased tumor epidermal growth factor receptor levels", Dis Colon Rectum, 46, pp.1391~1399 (2003)
- Doger FK, "Does the EGFR and VEGF expression predict the prognosis in colon cancer?", Eur Surg Res, 38, pp.540~544 (2006)
- Steele RJ, "Immunohistochemical detection of epidermal growth factor receptors on human colonic carcinomas", Br J Cancer, 61, pp.325~326 (1990)
- Kluftinger AM, "Correlation of epidermal growth factor receptor and c-erbB2 oncogene product to known prognostic indicators of colorectal cancer", Surg Oncol, 1, pp.97~105 (1992)
- Koretz K, "Expression of epidermal growth factor receptor in normal colorectal mucosa,adenoma,and carcinoma", Virchows Arch A Pathol Anat Histopathol, 416, pp.343~349 (1990)
- Scambia G, "Receptors for epidermal growth factor and steroid hormones in primary colorectal tumors", J Surg Oncol, 48, pp.183~187 (1991)
- Yasui W, "Expression of epidermal growth factor receptor in human gastric and colonic carcinomas", Cancer Res, 48, pp.137~141 (1988)
- Bradley SJ, "Increased expression of the epidermal growth factor receptor on human colon carcinoma cells", Arch Surg, 121, pp.1242~1247 (1986)
- Hase K, "Prognostic value of tumor"budding"in patients with colorectal cancer", Dis Colon Rectum, 36, pp.627~635 (1993)
- Prabhudesai A, "Impact of microscopic extranodal tumor deposits on the outcome of patients with rectal cancer", Dis Colon Rectum, 46, pp.1531~1537 (2003)
- Gabbert H, "Mechanisms of tumor invasion:evidence from in vivo observations", Cancer Metastasis Rev, 4, pp.293~309 (1985)
- Morodomi T, "Clinicopathological studies of advanced rectal cancers:prediction of the degree of lymph node metastasis from histopathological finding of pre-operative biopsy specimens", Nippon Geka Gakkai Zasshi, 89, pp.352~364 (1988)